Nauck, Michael A.
D‘Alessio, David A.
Funding for this research was provided by:
Katholisches Klinikum Bochum gGmbh
Article History
Received: 11 July 2022
Accepted: 19 August 2022
First Online: 1 September 2022
Declarations
:
: Not applicable.
: Not applicable.
: MAN has been member on advisory boards or has consulted with Boehringer Ingelheim, Eli Lilly & Co., Menarini/Berlin Chemie, Merck, Sharp & Dohme, NovoNordisk, Regor, and ShouTi Inc./Gasherbrum. He has received grant support from Merck, Sharp & Dohme. He is member of a data monitoring and safety board for Inventiva. He has also served on the speakers’ bureau of Eli Lilly & Co., Medscape, Medical Learning Institute, Menarini/Berlin Chemie, Merck, Sharp & Dohme, NovoNordisk, and Sun Pharmaceuticals. D.A.D. consults for Eli Lilly & Co. and Sun Pharmaceuticals.